Evaluation of mucosal healing effects of intensive-granulocyte monocyte absorptive apheresis in patients with ulcerative colitis - Evaluation of mucosal healing effects of intensive-GMA in ulcerative colitis patients

ational Defense Medical College0 个研究点目标入组 80 人开始时间: 2020年3月26日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1.Patients with granulocyte count 2,000/mm3 or less 2.Patients with serious infectious disease 3.Patients with proctitis 4.Patients who used of enema, suppository (mesalazine, sulfasalazine, steroids) within the last 2 weeks 5.Patients who started administration or increased the dosage of mesalazine, sulfasalazine within the last 4 weeks 6.Patients who started administration or increased the dosage of steroids (oral) within the last 2 weeks 7.Patients who received steroids (intravenous infusion) within the last 2 weeks 8.Patients who used of total parenteral nutrition within the last 4 weeks 9.Patients who received cyclosporine, tacrolimus within the last 4 weeks 10.Patients who started administration or increased the dosage of azathioprine, 6-mercaptopurine within the last 4 weeks 11.Patients who received infliximab within the last 6 weeks 12.Patients who used of GMA, LCAP within the last 8 weeks 13.Patients with history of colectomy 14.Patients with inappropriate for this study by doctor's judgement 15.Patients who refused to participate in this study

发起方

ational Defense Medical College